Droxidopa 300 MG Oral Capsule — RxCUI 1490038
RxNorm drug concept · Semantic clinical drug
RxCUI 1490038
Semantic clinical drug · SCD
● Current RxNorm concept 42 FDA products
51 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1490038
Official nameDroxidopa 300 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped42
Package NDCs mapped51
Reported Medicaid activity (SDUD)1,239 prescriptions · 13 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Droxidopa: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Droxidopa is designed to help with the dizziness, lightheadedness, and that scary 'about to pass out' feeling you get when you stand up too quickly. In your condition, your nervous...
- What exactly is this medication supposed to do for me?
- You'll take it three times a day — morning, midday, and late afternoon. The important rule is that your last dose must be at least 3 hours before you go to bed. As for food, it doe...
- How do I take it, and does it matter if I take it with food?
🕸️ Concept Web — How Droxidopa 300 MG Oral Capsule Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Droxidopa 300 MG Oral Capsule
RxCUI 1490038 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Droxidopa
1489913IN
-
Droxidopa
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Northera
1490027BN
-
Northera
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Droxidopa Oral Capsule
1490025SCDF -
Droxidopa Oral Product
1490023SCDG -
Droxidopa Pill
1490024SCDG -
Droxidopa Oral Capsule [Northera]
1490029SBDF -
Northera Oral Product
1490030SBDG -
Northera Pill
1490031SBDG -
Oral Capsule
316965DF -
Oral Product
1151131DFG - +1 more in this family
-
Droxidopa Oral Capsule
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Droxidopa 300 MG
1490037SCDC -
Droxidopa 300 MG Oral Capsule [Northera]
1490040SBD -
Droxidopa 300 MG [Northera]
1490039SBDC
-
Droxidopa 300 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Droxidopa 300 MG
SCDC · 1490037 -
Droxidopa Oral Capsule
SCDF · 1490025 -
Droxidopa Oral Product
SCDG · 1490023 -
Droxidopa Pill
SCDG · 1490024
Brand-Name Concepts
-
Droxidopa 300 MG Oral Capsule [Northera]
SBD · 1490040 -
Droxidopa 300 MG [Northera]
SBDC · 1490039 -
Droxidopa Oral Capsule [Northera]
SBDF · 1490029 -
Northera Oral Product
SBDG · 1490030 -
Northera Pill
SBDG · 1490031 -
Northera
BN · 1490027
📦 FDA Products & Package NDCs
42 products · 51 package NDCs
51 package NDCs map to RxCUI 1490038 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00904-7392-89 | 90 CAPSULE in 1 BOTTLE (0904-7392-89) | Droxidopa | MAJOR PHARMACEUTICALS | 2023-12-28 |
| 00904-7393-89 | 90 CAPSULE in 1 BOTTLE (0904-7393-89) | Droxidopa | MAJOR PHARMACEUTICALS | 2023-12-28 |
| 00904-7394-89 | 90 CAPSULE in 1 BOTTLE (0904-7394-89) | Droxidopa | MAJOR PHARMACEUTICALS | 2023-12-28 |
| 31722-0010-90 | 90 CAPSULE in 1 BOTTLE (31722-010-90) | Droxidopa | Camber Pharmaceuticals, Inc. | 2021-02-18 |
| 31722-0014-90 | 90 CAPSULE in 1 BOTTLE (31722-014-90) | Droxidopa | Camber Pharmaceuticals, Inc. | 2021-08-09 |
| 31722-0015-90 | 90 CAPSULE in 1 BOTTLE (31722-015-90) | Droxidopa | Camber Pharmaceuticals, Inc. | 2021-08-09 |
| 50228-0429-10 | 1000 CAPSULE in 1 BOTTLE (50228-429-10) | Droxidopa | ScieGen Pharmaceuticals Inc | 2021-02-18 |
| 50228-0429-30 | 30 CAPSULE in 1 BOTTLE (50228-429-30) | Droxidopa | ScieGen Pharmaceuticals Inc | 2021-02-18 |
| 50228-0429-90 | 90 CAPSULE in 1 BOTTLE (50228-429-90) | Droxidopa | ScieGen Pharmaceuticals Inc | 2021-02-18 |
| 50228-0430-10 | 1000 CAPSULE in 1 BOTTLE (50228-430-10) | Droxidopa | ScieGen Pharmaceuticals Inc | 2021-02-18 |
| 50228-0430-30 | 30 CAPSULE in 1 BOTTLE (50228-430-30) | Droxidopa | ScieGen Pharmaceuticals Inc | 2021-02-18 |
| 50228-0430-90 | 90 CAPSULE in 1 BOTTLE (50228-430-90) | Droxidopa | ScieGen Pharmaceuticals Inc | 2021-02-18 |
| 50228-0431-05 | 500 CAPSULE in 1 BOTTLE (50228-431-05) | Droxidopa | ScieGen Pharmaceuticals Inc | 2021-02-18 |
| 50228-0431-30 | 30 CAPSULE in 1 BOTTLE (50228-431-30) | Droxidopa | ScieGen Pharmaceuticals Inc | 2021-02-18 |
| 50228-0431-90 | 90 CAPSULE in 1 BOTTLE (50228-431-90) | Droxidopa | ScieGen Pharmaceuticals Inc | 2021-02-18 |
| 51407-0765-90 | 90 CAPSULE in 1 BOTTLE (51407-765-90) | Droxidopa | Golden State Medical Supply, Inc. | 2023-04-18 |
| 51407-0766-90 | 90 CAPSULE in 1 BOTTLE (51407-766-90) | Droxidopa | Golden State Medical Supply, Inc. | 2023-04-18 |
| 51407-0767-90 | 90 CAPSULE in 1 BOTTLE (51407-767-90) | Droxidopa | Golden State Medical Supply, Inc. | 2023-04-18 |
| 59651-0375-90 | 90 CAPSULE in 1 BOTTLE (59651-375-90) | Droxidopa | Aurobindo Pharma Limited | 2021-02-18 |
| 59651-0376-90 | 90 CAPSULE in 1 BOTTLE (59651-376-90) | Droxidopa | Aurobindo Pharma Limited | 2021-02-18 |
| 59651-0377-90 | 90 CAPSULE in 1 BOTTLE (59651-377-90) | Droxidopa | Aurobindo Pharma Limited | 2021-02-18 |
| 67386-0820-19 | 90 CAPSULE in 1 BOTTLE (67386-820-19) | Northera | Lundbeck Pharmaceuticals LLC | 2014-09-01 |
| 67386-0821-19 | 90 CAPSULE in 1 BOTTLE (67386-821-19) | Northera | Lundbeck Pharmaceuticals LLC | 2014-09-01 |
| 67386-0822-19 | 90 CAPSULE in 1 BOTTLE (67386-822-19) | Northera | Lundbeck Pharmaceuticals LLC | 2014-09-01 |
| 67877-0704-05 | 500 CAPSULE in 1 BOTTLE (67877-704-05) | Droxidopa | Ascend Laboratories, LLC | 2021-02-19 |
| 67877-0704-90 | 90 CAPSULE in 1 BOTTLE (67877-704-90) | Droxidopa | Ascend Laboratories, LLC | 2021-02-19 |
| 67877-0705-05 | 500 CAPSULE in 1 BOTTLE (67877-705-05) | Droxidopa | Ascend Laboratories, LLC | 2021-02-19 |
| 67877-0705-90 | 90 CAPSULE in 1 BOTTLE (67877-705-90) | Droxidopa | Ascend Laboratories, LLC | 2021-02-19 |
| 67877-0706-05 | 500 CAPSULE in 1 BOTTLE (67877-706-05) | Droxidopa | Ascend Laboratories, LLC | 2021-02-19 |
| 67877-0706-90 | 90 CAPSULE in 1 BOTTLE (67877-706-90) | Droxidopa | Ascend Laboratories, LLC | 2021-02-19 |
| 69452-0256-19 | 90 CAPSULE in 1 BOTTLE, PLASTIC (69452-256-19) | DROXIDOPA | Bionpharma Inc. | 2021-10-01 |
| 69452-0257-19 | 90 CAPSULE in 1 BOTTLE, PLASTIC (69452-257-19) | DROXIDOPA | Bionpharma Inc. | 2021-10-01 |
| 69452-0258-19 | 90 CAPSULE in 1 BOTTLE, PLASTIC (69452-258-19) | DROXIDOPA | Bionpharma Inc. | 2021-10-01 |
| 70436-0140-06 | 90 CAPSULE in 1 BOTTLE (70436-140-06) | droxidopa | Slate Run Pharmaceuticals, LLC | 2021-11-10 |
| 70436-0141-06 | 90 CAPSULE in 1 BOTTLE (70436-141-06) | droxidopa | Slate Run Pharmaceuticals, LLC | 2021-11-10 |
| 70436-0142-06 | 90 CAPSULE in 1 BOTTLE (70436-142-06) | droxidopa | Slate Run Pharmaceuticals, LLC | 2021-11-10 |
| 70710-1389-09 | 90 CAPSULE in 1 BOTTLE (70710-1389-9) | Droxidopa | Zydus Pharmaceuticals USA Inc. | 2021-02-19 |
| 70710-1390-09 | 90 CAPSULE in 1 BOTTLE (70710-1390-9) | Droxidopa | Zydus Pharmaceuticals USA Inc. | 2021-02-19 |
| 70710-1391-09 | 90 CAPSULE in 1 BOTTLE (70710-1391-9) | Droxidopa | Zydus Pharmaceuticals USA Inc. | 2021-02-19 |
| 70771-1609-09 | 90 CAPSULE in 1 BOTTLE (70771-1609-9) | Droxidopa | Zydus Lifesciences Limited | 2021-02-19 |
| 70771-1610-09 | 90 CAPSULE in 1 BOTTLE (70771-1610-9) | Droxidopa | Zydus Lifesciences Limited | 2021-02-19 |
| 70771-1611-09 | 90 CAPSULE in 1 BOTTLE (70771-1611-9) | Droxidopa | Zydus Lifesciences Limited | 2021-02-19 |
| 72205-0072-05 | 500 CAPSULE in 1 BOTTLE (72205-072-05) | Droxidopa | Novadoz Pharmaceuticals LLC | 2021-02-19 |
| 72205-0072-90 | 90 CAPSULE in 1 BOTTLE (72205-072-90) | Droxidopa | Novadoz Pharmaceuticals LLC | 2021-02-19 |
| 72205-0073-05 | 500 CAPSULE in 1 BOTTLE (72205-073-05) | Droxidopa | Novadoz Pharmaceuticals LLC | 2021-02-19 |
| 72205-0073-90 | 90 CAPSULE in 1 BOTTLE (72205-073-90) | Droxidopa | Novadoz Pharmaceuticals LLC | 2021-02-19 |
| 72205-0074-05 | 500 CAPSULE in 1 BOTTLE (72205-074-05) | Droxidopa | Novadoz Pharmaceuticals LLC | 2021-02-19 |
| 72205-0074-90 | 90 CAPSULE in 1 BOTTLE (72205-074-90) | Droxidopa | Novadoz Pharmaceuticals LLC | 2021-02-19 |
| 82249-0551-90 | 90 CAPSULE in 1 BOTTLE (82249-551-90) | Droxidopa | CivicaScript LLC | 2025-03-03 |
| 82249-0552-90 | 90 CAPSULE in 1 BOTTLE (82249-552-90) | Droxidopa | CivicaScript LLC | 2025-03-03 |
Observed labelers:
ScieGen Pharmaceuticals Inc (9) ·
Ascend Laboratories, LLC (6) ·
Novadoz Pharmaceuticals LLC (6) ·
Aurobindo Pharma Limited (3) ·
Bionpharma Inc. (3) ·
Camber Pharmaceuticals, Inc. (3)
· +8 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.